| NO. |
Chemical Name |
CAS NO. |
| Intermediates of Saxagliptin |
|
RD001
|
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide |
361440-68-8 |
|
RD002
|
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide, 2,2,2-trifluoroacetate (1:1) |
361440-69-9 |
|
RD003
|
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo |
361440-67-7 |
|
RD004
|
(S)-[[(1,1-dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo [3.3.1.13,7]decane-1-acetic acid |
361442-00-4 |
|
RD088
|
Saxagliptin hydrate |
945667-22-1 |
|
RD089
|
Saxagliptin hydrochloride monohydrate |
1370409-28-1 |
|
RD090
|
Saxagliptin hydrochloride dihydrate |
1073057-20-1 |
|
RD091
|
2-Azabicyclo[3.1.0]hexane-3-carboxamide, (1S,3S,5S)-, monomethane sulfonate |
709031-45-8 |
| Intermediates of Sitagliptin |
|
RD005
|
(3R)-3-(1,1-dimethylethoxy carbonyl)amino-4-(2,4,5-trifluorophenyl)butanoic acid |
486460-00-8 |
|
RD006
|
(S)-phenylglycinamide |
6485-52-5 |
|
RD007
|
2,4,5-trifluorophenylacetic acid |
209995-38-0 |
|
RD008
|
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride |
486460-21-3 |
|
RD083
|
Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate |
769195-26-8 |
|
RD084
|
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one |
764667-65-4 |
|
RD085
|
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine Hydrochloride |
762240-92-6 |
|
RD086
|
Sitagliptin phosphate monohydrate |
654671-77-9 |
| Intermediates of Pioglitazone |
|
RD009
|
2-(5-Ethyl-2-pyridinyl)ethanol |
5223-06-3 |
|
RD010
|
4-[2-(5-Ethyl-2-pyridinyl)ethoxy]nitrobenzene |
85583-54-6 |
|
RD011
|
Methyl 2-bromo-3-[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]propionate |
105355-25-7 |
|
RD012
|
imino-Pioglitazone;5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2-imino-4-thiazolidinone |
105355-26-8 |
|
RD013
|
Pioglitazone base |
111025-46-8 |
|
RD014
|
4-[2-(5-Ethyl-2-Pyridinyl)ethoxy]benzaldehyde |
114393-97-4 |
|
RD015
|
2,4-Thiazolidinedione |
2295-31-0 |
|
RD016
|
5-[[4-[2-(5-Ethyl-2-Pyridinyl)ethoxy]phenyl]methylene]-2,4-thiazolidinedione |
144809-28-9 |
| Intermediates of Rosiglitazone |
|
RD018
|
2,4-thiazolidinedione |
2295-31-0 |
|
RD019
|
4-[2-[methyl(pyridine-2-yl)amino]ethoxy]benzaldehyde |
122321-03-3 |
|
RD0
|
5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methylene]-2,4-thiazolidinedione |
122320-74-5 |
| Intermediates of Alogliptin |
|
RD022
|
2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl) methyl] benzonitrile |
865758-96-9 |
|
RD023
|
2-(Bromomethyl)benzonitrile |
22115-41-9 |
|
RD024
|
6-Chloro-3-methylpyrimidine-2,4(1H,3H)-dione |
4318-56-3 |
|
RD025
|
(S)-3-N-Boc-aminopiperidine |
216854-23-8 |
|
RD026
|
(R)-1-Boc-3-aminopiperidine |
188111-79-7 |
|
RD027
|
(R)-3-Aminopiperidine dihydrochloride |
334618-23-4 |
|
RD028
|
(R)-3-(Boc-Amino)piperidine |
309956-78-3 |
|
RD029
|
2-Cyano-5-Fluorobenzyl Bromide |
421552-12-7 |
| Intermediates of Canagliflozin |
|
RD073
|
Canagliflozin hemihydrate |
928672-86-0 |
|
RD074
|
2-[(5-Bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)thiophene |
1030825-20-7 |
|
RD075
|
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol tetraacetate |
866607-35-4
|
|
RD076
|
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone |
32384-65-9 |
|
RD077
|
(2S,3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-methylphenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol |
1358581-37-9 |
|
RD078
|
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene |
898566-17-1 |
|
RD079
|
2-(4-fluorophenyl)thiophene |
58861-48-6 |
| Intermediates of Dapagliflozin |
|
RD042
|
Dapagliflozin propanediol monohydrate |
960404-48-2 |
|
RD044
|
Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-alpha-D-glucopyranoside |
714269-57-5 |
|
RD045
|
5-Bromo-2-chlorobenzoic acid |
21739-92-4 |
|
RD046
|
(5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone |
461432-22-4 |
|
RD047
|
Benzene, 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]- |
461432-23-5 |
|
RD048
|
(2-chloro-5-iodophenyl)(4-ethoxyphenyl)methanone |
1103738-26-6 |
|
RD049
|
4-Iodo-1-chloro-2-(4-ethoxybenzyl)benzene |
1103738-29-9 |
| Intermediates of Empagliflozin |
|
RD073
|
|
865758-96-9 |
| Intermediates of Ertugliflozin |
|
RD073
|
|
865758-96-9 |
